6092 — Enbio Holdings Income Statement

0.000.00%

Last trade - 00:00

IndustrialsBalancedMicro CapValue Trap

Annual income statement for Enbio Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,841	8,988	8,120	9,576	10,668
Cost of Revenue
Gross Profit	1,890	2,426	2,764	2,484	2,654
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	6,339	7,855	6,873	8,762	9,829
Operating Profit	502	1,133	1,247	813	839
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	488	1,099	1,233	1,066	702
Provision for Income Taxes
Net Income After Taxes	331	707	795	740	420
Minority Interest
Net Income Before Extraordinary Items
Net Income	304	654	812	709	453
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	304	654	812	709	453
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	57.6	109	134	90	58.2
Dividends per Share